The pathogenic bacterium Listeria monocytogenes is the third most common cause of bacterial meningitis in neonates, and causes abortion and stillbirth. Additionally, sporadic outbreaks of listeriosis continue to claim lives, particularly in the very young and the elderly. Here, Jonathan Hardy and colleagues use in vivo bioluminescent imaging to visualize L. monocytogenes in mice. They found that live and attenuated forms of the bacterium reside in the bone marrow and persist for weeks following acute infection. The results draw attention to the bone marrow as a site of residual infection, both during and after treatment. Additionally, this study demonstrates that growth mechanisms still function in attenuated Listeria strains enabling the bacteria to colonize the bone marrow, which is important because these attenuated strains are being tested for their ability to induce anti-tumor immune responses in cancer patients.
Shedding light on chronic Listeria infection
Shedding light on chronic Listeria infection. Dis Model Mech 7 January 2009; 2 (1-2): 1. doi:
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists